4//SEC Filing
Curran Terrie 4
Accession 0000950170-25-031048
CIK 0001783183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:16 PM ET
Size
5.5 KB
Accession
0000950170-25-031048
Insider Transaction Report
Form 4
Curran Terrie
DirectorPresident and Chief Executive
Transactions
- Award
Stock Option (Right to Buy)
2025-02-27+342,500→ 342,500 totalExercise: $5.76Exp: 2035-02-26→ Common Stock (342,500 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the shares of common stock on February 27, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001690298
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:16 PM ET
- Size
- 5.5 KB